Results 221 to 230 of about 156,412 (306)
Korean Medication Algorithm for Depressive Disorder 2025, Fifth Revision: An Executive Summary. [PDF]
Kim NY +18 more
europepmc +1 more source
An Unusual Motor OFF in Parkinson's Disease
Movement Disorders Clinical Practice, EarlyView.
Shreyashi Jha, Mandar S. Jog
wiley +1 more source
Abstract Post COVID‐19 condition (PCC) or long COVID disproportionately affects racial and ethnic minority communities. There are a growing number of rehabilitation studies for PCC, however, it has yet to be determined whether existing studies take race and ethnicity into account in their study designs and whether existing rehabilitative approaches are
Nadine Akbar +5 more
wiley +1 more source
PEPAMARKER: a multicenter cohort study protocol on predictive biomarkers of affective vs. non-affective trajectories in first-episode psychosis. [PDF]
Terrisse R +4 more
europepmc +1 more source
Abstract Background Late effects of polio (LEoP) is a progressive condition leading to a lifelong disability that can affect mental health. There is limited knowledge of depressive symptoms and associated factors in people with LEoP. Objective To assess the occurrence of depressive symptoms in people with LEoP and explore the association with ...
Maria Nolvi +3 more
wiley +1 more source
Age of onset and course and outcome of bipolar disorder: Findings from the bipolar disorder course and outcome study from India (BiD-CoIN study). [PDF]
Grover S +16 more
europepmc +1 more source
Rehabilitation needs of long COVID patients in British Columbia
Abstract Introduction COVID‐19 can result in persistent symptoms and functional impairment that significantly impact daily functioning, highlighting the need for targeted rehabilitation. However, there is a lack of data on what proportion of long COVID patients need rehabilitation and which types are required.
Débora M. Petry Moecke +6 more
wiley +1 more source
Modeling effect: How treatment intensity and duration impact depression recurrence. [PDF]
Li F +5 more
europepmc +1 more source
The General Disease Factor (“d”): First Empirical Evidence From China
Med Research, EarlyView.
Hongyi Sun +4 more
wiley +1 more source
Abstract Intranasal diamorphine (IND), approved for managing breakthrough pain in the UK, has been identified as an acceptable alternative offering effective, expedient, and less traumatic analgesia for children. However, the current dose regimen in pediatric populations relies on clinical expertise while the pharmacokinetics properties are poorly ...
Lianjin Cai +6 more
wiley +1 more source

